QUIDELORTHO CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-01-01 was 283.00K shares.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-10-02 was 0.00 shares.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 70.00K shares, a 33.96% decline from fiscal 2024.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 106.00K shares, a 0.93% decline from fiscal 2023.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 107.00K shares, a 72.06% decline from fiscal 2023.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 383.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-28 | 70.00K shares 10-K · filed 2026-02-19 | |
| 2024-12-29 | 106.00K shares 10-K · filed 2025-02-27 | |
| 2023-12-31 | 107.00K shares 10-K/A · filed 2024-08-01 | |
| 2023-01-01 | 283.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 383.00K shares 10-K · filed 2023-02-23 |
| 2022-10-02 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |